価格表

在庫・価格 : 2025年04月27日 05時53分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
GDF-15, Human, ELISA Kit, Quantikine (96well)
データシート※最新のデータシートでない場合があります
DGD150 RSDアールアンドディー システムズ
R&D Systems, Inc.
1 kit ¥116,000
(発注済)
追加

在庫・価格 : 2025年04月27日 05時53分 現在

GDF-15, Human, ELISA Kit, Quantikine (96well)

  • 商品コード:DGD150
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:無(発注済)
使用文献
No. 文献情報 備考 参照
1 Ashby DR et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009 May;75(9):976-81
Ashby DR et al
2009/01/01
Sample Type: Plasma PubMed
2 Darmanis S et al. Sensitive plasma protein analysis by microparticle-based proximity ligation assays. Mol. Cell Proteomics 2010 Feb;9(2):327-35
Darmanis S et al
2010/01/01
Sample Type: Plasma (Not Specified) PubMed
3 Piperno A et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood 2011 Mar;117(10):2953-9
Piperno A et al
2011/01/01
Sample Type: Serum PubMed
4 Vila G et al. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin. Chem. 2011 Feb;57(2):309-16
Vila G et al
2011/01/01
Sample Type: Plasma (EDTA) PubMed
5 Wei J et al. Hypoxia potentiates glioma-mediated immunosuppression. PLoS ONE 2011;6(1):e16195
Wei J et al
2011/01/01
Sample Type: Cell Supernates PubMed
6 Si Y et al. Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS ONE 2011;6(5):e19967
Si Y et al
2011/01/01
Sample Type: Cell Supernates,Serum PubMed
7 Talbot NP et al. Regulation of hepcidin expression at high altitude. Blood 2012 Jan;119(3):857-60
Talbot NP et al
2012/01/01
Sample Type: Plasma PubMed
8 Aksoy C et al. Bone marrow mesenchymal stem cells in patients with beta thalassemia major: molecular analysis with attenuated total reflection-Fourier transform infrared spectroscopy study as a novel method. Stem Cells Dev. 2012 Jul;21(11):2000-11
Aksoy C et al
2012/01/01
Sample Type: Bone Marrow Plasma PubMed
9 Andr辿 T et al. Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS ONE 2013;8(3):e59756
Andr辿 T et al
2013/01/01
Sample Type: cell supernates PubMed
10 Fujiwara T et al. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease. PLoS ONE 2013;8(9):e75568
Fujiwara T et al
2013/01/01
Sample Type: Whole Cells PubMed
11 Kahli A et al. Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. PLoS ONE 2014;9(8):e105759
Kahli A et al
2014/01/01
Sample Type: Plasma PubMed
12 Jeansonne D et al. Anti-tumoral effects of miR-3189-3p in glioblastoma. J. Biol. Chem. 2015 Mar;290(13):8067-80
Jeansonne D et al
2015/01/01
Sample Type: Conditioned media PubMed
13 Urakawa N et al. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways. Lab. Invest. 2015 May;95(5):491-503
Urakawa N et al
2015/01/01
Sample Type: Cell Culture Supernates PubMed
14 Mahon KL et al. Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. Br. J. Cancer 2015 Apr;112(8):1340-8
Mahon KL et al
2015/01/01
Sample Type: Conditioned media PubMed
15 Yuan Z et al. Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting. Sci Rep 2016 Jun;6:28221
Yuan Z et al
2016/01/01
Sample Type: Plasma PubMed
16 Yang Y et al. Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion. PLoS ONE 2017;12(1):e0169665
Yang Y et al
2017/01/01
Sample Type: Cell Culture Supernates PubMed
17 Matsuhashi T et al. Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases. EBioMedicine 2017 Jun;20:27-38
Matsuhashi T et al
2017/01/01
Species: Human PubMed
18 Sun L et al. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study. PLoS ONE 2018;13(5):e0197609
Sun L et al
2018/01/01
Species: Human PubMed
19 Babic A et al. Plasma inflammatory cytokines and survival of pancreatic cancer patients. Clin Transl Gastroenterol 2018 Apr;9(4):145
Babic A et al
2018/01/01
Species: Human PubMed
20 Sun L et al. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis. PLoS ONE 2018;13(3):e0194152
Sun L et al
2018/01/01
Species: Human PubMed
21 Sugimoto M et al. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer. Sci Rep 2017 Aug;7(1):9198
Sugimoto M et al
2017/01/01
Species: Human PubMed
22 Stojkovic S et al. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2. J. Cell. Mol. Med. 2018 Apr;22(4):2422-2429
Stojkovic S et al
2018/01/01
Species: Human PubMed
23 Ban N et al. GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients. JCI Insight 2017 May;2(9)
Ban N et al
2017/01/01
Species: Human PubMed
24 Jeay S et al. Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201. Cancer Res. 2018 Nov;78(21):6257-6267
Jeay S et al
2018/01/01
PubMed
25 Ratnam NM et al. NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. J. Clin. Invest. 2017 Oct;127(10):3796-3809
Ratnam NM et al
2017/01/01
PubMed
26 Traeger L et al. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma. BMC Cancer 2019 Jan;19(1):74
Traeger L et al
2019/01/01
PubMed
27 Wu CK et al. Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J Clin Med 2018 Nov;7(11)
Wu CK et al
2018/01/01
PubMed
28 Engerud H et al. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLoS ONE 2019;14(1):e0210585
Engerud H et al
2019/01/01
PubMed
29 Ham YR et al. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study. Dis. Markers 2018;2018:1463940
Ham YR et al
2018/01/01
PubMed
30 Buendgens L et al. Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis. Dis. Markers 2017;2017:5271203
Buendgens L et al
2017/01/01
PubMed
31 Li S et al. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J. Exp. Clin. Cancer Res. 2018 Apr;37(1):80
Li S et al
2018/01/01
PubMed
32 Schernthaner-Reiter MH et al. Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity. Eur. J. Endocrinol. 2016 Dec;175(6):623-631
Schernthaner-Reiter MH et al
2016/01/01
PubMed
33 Kleinert M et al. Exercise increases circulating GDF15 in humans. Mol Metab 2018 Mar;9:187-191
Kleinert M et al
2018/01/01
PubMed
34 Nakajima T et al. Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients. J Clin Med 2019 Oct;8(10)
Nakajima T et al
2019/01/01
PubMed
35 Kagiyama Y et al. Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt. J Cardiol 2020 06;75(6):697-701
Kagiyama Y et al
2020/01/01
PubMed
36 Richter B et al. Growth differentiation factor-15 predicts poor survival after cardiac arrest. Resuscitation 2019 10;143:22-28
Richter B et al
2019/01/01
PubMed
37 Scherzer R et al. Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection. Circ Heart Fail 2018 04;11(4):e004312
Scherzer R et al
2018/01/01
PubMed
38 Miyauchi A et al. Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease. Mitochondrion 2019 11;49:111-120
Miyauchi A et al
2019/01/01
PubMed
39 Noren Hooten N et al. Association of Extracellular Vesicle Protein Cargo with Race and Clinical Markers of Mortality. Sci Rep 2019 11;9(1):17582
Noren Hooten N et al
2019/01/01
PubMed
40 Wada H et al. Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study. J Am Heart Assoc 2020 11;9(22):e018217
Wada H et al
2020/01/01
Species: Human PubMed
41 Oikawa Y et al. Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5. PLoS One 2020;15(12):e0231064
Oikawa Y et al
2020/01/01
Species: Human PubMed
42 Kato T et al. Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery. J Clin Med 2021 May;10(9)
Kato T et al
2021/01/01
Species: Human PubMed
43 Bauer S et al. Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies. Br J Cancer 2021 Aug;125(5):687-698
Bauer S et al
2021/01/01
Species: Human PubMed
44 Guinot PG et al. Anaesthesia and ICU sedation with sevoflurane do not reduce myocardial injury in patients undergoing cardiac surgery: A randomized prospective study. Medicine (Baltimore) 2020 Dec;99(50):e23253
Guinot PG et al
2020/01/01
Species: Human PubMed
45 de Cos Gomez M et al. Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant Candidates. J Clin Med 2020 Dec;9(12)
de Cos Gomez M et al
2020/01/01
Species: Human PubMed
46 Mitic VT et al. Cardiac Remodeling Biomarkers as Potential Circulating Markers of Left Ventricular Hypertrophy in Heart Failure with Preserved Ejection Fraction. Tohoku J Exp Med 2020 04;250(4):233-242
Mitic VT et al
2020/01/01
Species: Human PubMed
47 De Jesus DF et al. Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice. J Clin Invest 2020 05;130(5):2391-2407
De Jesus DF et al
2020/01/01
Species: Human PubMed
48 Hannappe MA et al. Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. Sci Rep 2020 10;10(1):16718
Hannappe MA et al
2020/01/01
Species: Human PubMed
49 Crake RLI et al. Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study. Sci Rep 2021 Mar;11(1):5648
Crake RLI et al
2021/01/01
Species: Human PubMed
50 Bening C et al. Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease. BMC Cardiovasc Disord 2021 03;21(1):125
Bening C et al
2021/01/01
Species: Human PubMed
51 Yazawa H et al. Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females. Int J Cardiol Heart Vasc 2020 Dec;31:100651
Yazawa H et al
2020/01/01
Species: Human PubMed
52 Izaguirre DI et al. The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy. Cancers (Basel) 2020 Oct;12(10)
Izaguirre DI et al
2020/01/01
Species: Mouse PubMed
53 Van Dyck L et al. The clinical potential of GDF15 as a "ready-to-feed indicator" for critically ill adults. Crit Care 2020 09;24(1):557
Van Dyck L et al
2020/01/01
Species: Human PubMed
54 Zhao Z et al. Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. Aging (Albany NY) 2020 11;12(22):22564-22581
Zhao Z et al
2020/01/01
Species: Human PubMed
55 Freeman DW et al. Association between GDF15, poverty and mortality in urban middle-aged African American and white adults. PLoS One 2020;15(8):e0237059
Freeman DW et al
2020/01/01
Species: Human PubMed
56 Hong Y et al. Quercetin Induces Anticancer Activity by Upregulating Pro-NAG-1/GDF15 in Differentiated Thyroid Cancer Cells. Cancers (Basel) 2021 Jun;13(12)
Hong Y et al
2021/01/01
Species: Human PubMed
57 Borner T et al. GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss. Cell Rep 2020 04;31(3):107543
Borner T et al
2020/01/01
Species: Rat PubMed
58 Kim H et al. Growth differentiation factor-15 as a biomarker for sarcopenia in aging humans and mice. Exp Gerontol 2020 12;142:111115
Kim H et al
2020/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Ashby DR et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009 May;75(9):976-81
    Ashby DR et al
    2009/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Darmanis S et al. Sensitive plasma protein analysis by microparticle-based proximity ligation assays. Mol. Cell Proteomics 2010 Feb;9(2):327-35
    Darmanis S et al
    2010/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Piperno A et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood 2011 Mar;117(10):2953-9
    Piperno A et al
    2011/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Vila G et al. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin. Chem. 2011 Feb;57(2):309-16
    Vila G et al
    2011/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Wei J et al. Hypoxia potentiates glioma-mediated immunosuppression. PLoS ONE 2011;6(1):e16195
    Wei J et al
    2011/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Si Y et al. Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS ONE 2011;6(5):e19967
    Si Y et al
    2011/01/01
  • 備考:
    Sample Type: Cell Supernates,Serum
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Talbot NP et al. Regulation of hepcidin expression at high altitude. Blood 2012 Jan;119(3):857-60
    Talbot NP et al
    2012/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Aksoy C et al. Bone marrow mesenchymal stem cells in patients with beta thalassemia major: molecular analysis with attenuated total reflection-Fourier transform infrared spectroscopy study as a novel method. Stem Cells Dev. 2012 Jul;21(11):2000-11
    Aksoy C et al
    2012/01/01
  • 備考:
    Sample Type: Bone Marrow Plasma
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Andr辿 T et al. Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS ONE 2013;8(3):e59756
    Andr辿 T et al
    2013/01/01
  • 備考:
    Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Fujiwara T et al. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease. PLoS ONE 2013;8(9):e75568
    Fujiwara T et al
    2013/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Kahli A et al. Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. PLoS ONE 2014;9(8):e105759
    Kahli A et al
    2014/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Jeansonne D et al. Anti-tumoral effects of miR-3189-3p in glioblastoma. J. Biol. Chem. 2015 Mar;290(13):8067-80
    Jeansonne D et al
    2015/01/01
  • 備考:
    Sample Type: Conditioned media
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Urakawa N et al. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways. Lab. Invest. 2015 May;95(5):491-503
    Urakawa N et al
    2015/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Mahon KL et al. Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. Br. J. Cancer 2015 Apr;112(8):1340-8
    Mahon KL et al
    2015/01/01
  • 備考:
    Sample Type: Conditioned media
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Yuan Z et al. Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting. Sci Rep 2016 Jun;6:28221
    Yuan Z et al
    2016/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Yang Y et al. Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion. PLoS ONE 2017;12(1):e0169665
    Yang Y et al
    2017/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Matsuhashi T et al. Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases. EBioMedicine 2017 Jun;20:27-38
    Matsuhashi T et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Sun L et al. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study. PLoS ONE 2018;13(5):e0197609
    Sun L et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Babic A et al. Plasma inflammatory cytokines and survival of pancreatic cancer patients. Clin Transl Gastroenterol 2018 Apr;9(4):145
    Babic A et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Sun L et al. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis. PLoS ONE 2018;13(3):e0194152
    Sun L et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Sugimoto M et al. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer. Sci Rep 2017 Aug;7(1):9198
    Sugimoto M et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Stojkovic S et al. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2. J. Cell. Mol. Med. 2018 Apr;22(4):2422-2429
    Stojkovic S et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Ban N et al. GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients. JCI Insight 2017 May;2(9)
    Ban N et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Jeay S et al. Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201. Cancer Res. 2018 Nov;78(21):6257-6267
    Jeay S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Ratnam NM et al. NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. J. Clin. Invest. 2017 Oct;127(10):3796-3809
    Ratnam NM et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Traeger L et al. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma. BMC Cancer 2019 Jan;19(1):74
    Traeger L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Wu CK et al. Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J Clin Med 2018 Nov;7(11)
    Wu CK et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Engerud H et al. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLoS ONE 2019;14(1):e0210585
    Engerud H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Ham YR et al. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study. Dis. Markers 2018;2018:1463940
    Ham YR et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Buendgens L et al. Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis. Dis. Markers 2017;2017:5271203
    Buendgens L et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Li S et al. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J. Exp. Clin. Cancer Res. 2018 Apr;37(1):80
    Li S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Schernthaner-Reiter MH et al. Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity. Eur. J. Endocrinol. 2016 Dec;175(6):623-631
    Schernthaner-Reiter MH et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Kleinert M et al. Exercise increases circulating GDF15 in humans. Mol Metab 2018 Mar;9:187-191
    Kleinert M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Nakajima T et al. Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients. J Clin Med 2019 Oct;8(10)
    Nakajima T et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Kagiyama Y et al. Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt. J Cardiol 2020 06;75(6):697-701
    Kagiyama Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Richter B et al. Growth differentiation factor-15 predicts poor survival after cardiac arrest. Resuscitation 2019 10;143:22-28
    Richter B et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Scherzer R et al. Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection. Circ Heart Fail 2018 04;11(4):e004312
    Scherzer R et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Miyauchi A et al. Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease. Mitochondrion 2019 11;49:111-120
    Miyauchi A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Noren Hooten N et al. Association of Extracellular Vesicle Protein Cargo with Race and Clinical Markers of Mortality. Sci Rep 2019 11;9(1):17582
    Noren Hooten N et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Wada H et al. Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study. J Am Heart Assoc 2020 11;9(22):e018217
    Wada H et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Oikawa Y et al. Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5. PLoS One 2020;15(12):e0231064
    Oikawa Y et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Kato T et al. Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery. J Clin Med 2021 May;10(9)
    Kato T et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Bauer S et al. Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies. Br J Cancer 2021 Aug;125(5):687-698
    Bauer S et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Guinot PG et al. Anaesthesia and ICU sedation with sevoflurane do not reduce myocardial injury in patients undergoing cardiac surgery: A randomized prospective study. Medicine (Baltimore) 2020 Dec;99(50):e23253
    Guinot PG et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    de Cos Gomez M et al. Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant Candidates. J Clin Med 2020 Dec;9(12)
    de Cos Gomez M et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Mitic VT et al. Cardiac Remodeling Biomarkers as Potential Circulating Markers of Left Ventricular Hypertrophy in Heart Failure with Preserved Ejection Fraction. Tohoku J Exp Med 2020 04;250(4):233-242
    Mitic VT et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    De Jesus DF et al. Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice. J Clin Invest 2020 05;130(5):2391-2407
    De Jesus DF et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Hannappe MA et al. Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. Sci Rep 2020 10;10(1):16718
    Hannappe MA et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Crake RLI et al. Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study. Sci Rep 2021 Mar;11(1):5648
    Crake RLI et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Bening C et al. Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease. BMC Cardiovasc Disord 2021 03;21(1):125
    Bening C et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Yazawa H et al. Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females. Int J Cardiol Heart Vasc 2020 Dec;31:100651
    Yazawa H et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Izaguirre DI et al. The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy. Cancers (Basel) 2020 Oct;12(10)
    Izaguirre DI et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Van Dyck L et al. The clinical potential of GDF15 as a "ready-to-feed indicator" for critically ill adults. Crit Care 2020 09;24(1):557
    Van Dyck L et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Zhao Z et al. Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. Aging (Albany NY) 2020 11;12(22):22564-22581
    Zhao Z et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Freeman DW et al. Association between GDF15, poverty and mortality in urban middle-aged African American and white adults. PLoS One 2020;15(8):e0237059
    Freeman DW et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Hong Y et al. Quercetin Induces Anticancer Activity by Upregulating Pro-NAG-1/GDF15 in Differentiated Thyroid Cancer Cells. Cancers (Basel) 2021 Jun;13(12)
    Hong Y et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Borner T et al. GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss. Cell Rep 2020 04;31(3):107543
    Borner T et al
    2020/01/01
  • 備考:
    Species: Rat
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Kim H et al. Growth differentiation factor-15 as a biomarker for sarcopenia in aging humans and mice. Exp Gerontol 2020 12;142:111115
    Kim H et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed